Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Aparna Parikh
9
Mins
April 2024
Once I got into fellowship, and started to see a lot of GI patients, I found a tremendous affinity towards this patient population…
Read more
8
Mins
26th August 2020
Review of the Latest Developments in Treatment of Hormone Receptor-Positive Advanced Breast Cancer
MONARCH 2 was a global, randomised, double-blind, Phase III study of abemaciclib or placebo in combination with fulvestrant in premenopausal…
14
Mins
26th August 2020
Latest Developments in Advanced Breast Cancer Treatment: A Discussion with Two Key Opinion Leaders about the CDK4/6 Inhibitors Abemaciclib, Palbociclib, and Ribociclib
The introduction of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in the treatment of advanced breast cancer (ABC; inoperable locally advanced…
10
Mins
24th August 2020
Adaptations and Advancement of Biologic Immunotherapy in the Management of Immunologically Cold Solid Malignancies
Contemporary breakthroughs within cancer immunotherapy are frequently cited amongst the most promising of therapeutic directions for medical oncology…
10
Mins
4th August 2020
Initiatives to Improve Control, Resource Use, and Quality of Life Associated with Chemotherapy-Induced Nausea and Vomiting
This review set out to identify the initiatives needed to achieve better cancer-induced nausea and vomiting (CINV) control worldwide…
9
Mins
23rd June 2020
Breast Cancer Immunotherapy: From Biology to Current Clinical Applications
The complexity behind the treatment of breast cancer arises, in part, from the presence of biologically distinct subtypes…
4
Mins
18th May 2020
The COVID-19 Conundrum and Cancer – Making Perfect Sense of Imperfect Data
March 11th 2020 marked the day that the World Health Organization (WHO) escalated the coronavirus SARS-CoV-2 (COVID-19) outbreak from a public health…
12
Mins
24th February 2020
From Traditional Histology to Next-Generation Pathology: A Review of The Workflow for the Characterisation and Molecular Profiling of Non-Small Cell Lung Cancer Samples
In accordance with ‘taking care’ of the cancer patient, the management of non-small cell lung cancer (NSCLC) is currently carried…
12
Mins
8th January 2020
Editor's Pick: Precision Medicine in Lung Cancer
Lung cancer has a devastating global impact. Claiming over 2 million lives in 2018, it is the world’s leading cause of cancer-related morbidity…
Loading posts...
« Previous
1
…
10
11
12
13
14
…
26
Next »